Reproduce “A Breast Vision Pathology Foundation Model for Real-world Clinical Utility” on OpenResearch

Turn your favorite coding agents into research agents that review literature, develop hypotheses, and run experiments.

Universal app for Apple silicon and Intel. Requires macOS 11 or later.

About this paper

Yingxue Xu, Zhengyu Zhang, Xiuming Zhang, Mengwei Xu, Fengtao Zhou, Yihui Wang, Jiabo Ma, Yi Xin and 27 more

Researchers developed BRAVE, a breast-adaptive pathology foundation model, and rigorously validated its clinical utility across the entire breast cancer patient pathway using a comprehensive multi-stage framework. The model improved pathologists' average balanced diagnostic accuracy by 7.5% and reduced reading time by 18.8% in a crossover study, while also demonstrating utility in safe triage, biomarker rescue, and extracting independent prognostic information from H&E slides.

Key insights

  • Breast-specific adaptation of a foundation model significantly improves performance on fine-grained and complex breast pathology tasks compared to general pan-cancer models.
  • AI can extract subtle, sub-visual biological information from routine H&E slides, such as mutation status and independent prognostic factors, which are not readily apparent to human pathologists.
  • Integrating AI into diagnostic workflows, as demonstrated in human-AI collaboration, measurably improves pathologist accuracy, efficiency, confidence, and inter-rater agreement, particularly for junior pathologists.

Summary by alphaXiv.

Tip: change arxiv.org to autoarxiv.org in any arXiv abstract link to open the paper here.